2023 2022 2021 2020 2019 2018 2017 2016 2015 Event Publication Document SITC 2023 10.2 MB Ongoing Phase 1 study of MP0317, a FAP-CD40 DARPin, shows a favorable safety profile and early evidence of tumor-localized CD40 activation in patients with advanced solid tumors EANM 2023 2.4 MB Radio-DARPin Therapy: Development of powerful targeting agents to treat cancer Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2.6 MB Development of powerful targeting agents for Radio-DARPin Therapy ASCO 2023 29.9 MB ASCO presentation video summary: Clinical update of Phase I study of MP0317 ASCO 2023 7.8 MB Phase I study of MP0317, a FAP-dependent DARPin for tumor-localized CD40 activation in patients with advanced solid tumors AACR 2023 2 MB DARPins as Powerful Targeting Agents for Radioligand Therapeutics 12th International Symposium on Targeted Alpha Therapy (TAT 12) 1.6 MB DARPins as Powerful Targeting Agents for Radioligand Therapeutics